Home/ Stocks/ KRSA

Korsana Biosciences, Inc. Common Stock

KRSA XNAS

$31.05 +0.62 (+2.04%) ▲ 15-min delayed

Open

$29.82

High

$31.20

Low

$29.70

Volume

65.6K

Market Cap

$1.41B

About Korsana Biosciences, Inc. Common Stock

Korsana Biosciences Inc is a biopharmaceutical company developing therapeutics to treat neurodegenerative diseases beginning with Alzheimer's disease (AD. The company's flagship product candidate, KRSA-028, is an anti-amyloid beta antibody that combines the proprietary Therapeutic Targeting (THETA) platform with well-validated aspects from other anti-Ab products that have achieved regulatory approval or are in late-stage clinical trials.

Sector: PHARMACEUTICAL PREPARATIONS Website →

Related Market News

No specific coverage for KRSA yet. Check out our latest market news or earnings calendar.

Get KRSA Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Korsana Biosciences, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.